HCAT – health catalyst, inc - common stock (US:NASDAQ)
Stock Stats
News
Health Catalyst (NASDAQ:HCAT) had its price target lowered by analysts at Citigroup Inc. from $3.25 to $2.75. They now have a "neutral" rating on the stock.
Matt Arens, CEO and Founder of Health Catalyst's Largest Shareholder, First Light Asset Management, Joins Board of Directors
Health Catalyst to Participate in Upcoming Investor Conferences
Health Catalyst Inc (HCAT) Q3 2025 Earnings Call Highlights: Strong Technology Growth Amid ... [Yahoo! Finance]
Health Catalyst (NASDAQ:HCAT) had its price target lowered by analysts at Citigroup Inc. from $3.50 to $3.25. They now have a "neutral" rating on the stock.
Form SCHEDULE 13G/A Health Catalyst, Inc. Filed by: Whetstone Capital Advisors, LLC
Form 8-K Health Catalyst, Inc. For: Jan 12
Form SCHEDULE 13G Health Catalyst, Inc. Filed by: Stoney Lonesome HF LP
Form 4 Health Catalyst, Inc. For: Dec 05 Filed by: Landry Benjamin
Form 4 Health Catalyst, Inc. For: Dec 04 Filed by: Larson-Green Julie
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.